. Here, we show that Bcl-2 also plays a role in regulating axonal growth rates in embryonic neurons. Sensory neurons from the trigeminal ganglia of bcl-2-deficient mouse embryos, removed from the embryo on embryonic day 11 or 12, extend axons more slowly in vitro than do neurons from wild-type embryos of the same age. Serial measurements of axonal length in the same neurons revealed that there were marked differences in axonal growth rate between bcl-2-deficient and wild-type neurons, irrespective of whether the neurons were grown with nerve growth factor, brain-derived neurotrophic factor or neurotrophin-3. Because there was no significant difference in the numbers of wild-type and bcl-2-deficient neurons surviving with each neurotrophin at this early stage of development, the effect of Bcl-2 on axonal growth rate is not a consequence of its well documented role in preventing apoptosis. 
Bcl-2 influences axonal growth rate in embryonic sensory neurons
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Bcl-2 plays a key role in regulating cell survival in the immune and nervous systems. Mice lacking the bcl-2 gene have markedly reduced numbers of B and T cells as a result of increased apoptosis [1] [2] [3] , whereas mice with a transgene causing high levels of Bcl-2 expression in the immune system show extended survival of B and T cells [4, 5] . Overexpression of Bcl-2 in cultured neurons prevents their death following neurotrophin deprivation [6, 7] , and mice with a bcl-2 transgene under the control of a neuron-specific enolase promoter have increased numbers of neurons in several regions [8] . Cultured neurons expressing antisense bcl-2 RNA have an attenuated survival response to neurotrophins [9] , and neurons of postnatal bcl-2-deficient mice die more rapidly following NGF deprivation in vitro [10] and are present in reduced numbers in vivo [11] . Here, we show that Bcl-2 also plays a role in regulating axonal growth rates in embryonic neurons. Sensory neurons from the trigeminal ganglia of bcl-2-deficient mouse embryos, removed from the embryo on embryonic day 11 or 12, extend axons more slowly in vitro than do neurons from wild-type embryos of the same age. Serial measurements of axonal length in the same neurons revealed that there were marked differences in axonal growth rate between bcl-2-deficient and wild-type neurons, irrespective of whether the neurons were grown with nerve growth factor, brain-derived neurotrophic factor or neurotrophin-3. Because there was no significant difference in the numbers of wild-type and bcl-2-deficient neurons surviving with each neurotrophin at this early stage of development, the effect of Bcl-2 on axonal growth rate is not a consequence of its well documented role in preventing apoptosis.
Results and discussion
In the course of studying early sensory neurons from bcl-2-null mutant (bcl-2 -/-) mouse embryos in vitro, we observed that these neurons had shorter axons than wild-type neurons. To ascertain whether this was due to a reduced rate of axonal growth, we carried out a detailed comparative study of axonal growth rate in low-density dissociated cultures of trigeminal ganglion neurons established from bcl-2 -/-and wild-type embryos at embryonic day 11 or 12 (E11 or E12), when many trigeminal axons are growing to their peripheral and central targets in vivo [12] . Because some neurons are generated from progenitor cells in dissociated cultures of early trigeminal ganglia [13] and start extending axons at different times in the cultures, it was essential to make serial measurements of axonal length of the same neurons at intervals in culture in order to obtain an accurate measure of axonal growth rate. Because many trigeminal neurons switch from being dependent for survival on brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT3) to being dependent on nerve growth factor (NGF) between E11 and E12 [13] [14] [15] [16] , E11 neurons were grown with either BDNF or NT3, and E12 neurons were grown with NGF. Figure 1 shows that, at both ages, neurons from bcl-2 -/-embryos extended axons at a slower rate than those from either bcl-2 +/-or bcl-2 +/+ embryos. After 48 h incubation, bcl-2-deficient neurons were between 44 and 60% shorter than wild-type neurons in E11 cultures and were 35% shorter in E12 cultures. The differences in axonal length between the neurons of bcl-2 -/-and bcl-2 +/+ embryos were statistically significant at 12, 24 and 48 h incubation (p < 0.0001 in all cases, using t tests; n = 124 in cultures of E11 neurons grown with BDNF, n = 152 in cultures of E11 neurons grown with NT3 and n = 197 in E12 cultures). Neurons from bcl-2 +/+ and bcl-2 +/-embryos grew at similar rates. Because only neurons that survived throughout the 48 h period of study were included in the analysis, differences in axonal growth rate between bcl-2-deficient and wild-type embryos were not due to differences in survival. Even so, there were no significant differences in the overall percentage survival of bcl-2-deficient and wild-type neurons in these cohorts after 48 h incubation under each experimental condition (E11 neurons plus BDNF, wild-type = 55.4 ± 5.2%, bcl-2 -/-= 54.1 ± 4.4%; E11 neurons plus NT3, wild-type = 55.8 ± 2.9%, bcl-2 -/-= 49.4 ± 1.6%; E12 neurons plus NGF, wild-type = 59.3 ± 2.4%, bcl-2 -/-= 56.4 ± 2.6%; p > 0.05 in all cases, using t tests). Furthermore, these results were not influenced by observer bias, because the genotypes were ascertained after all measurements were made. These results therefore suggest that endogenous bcl-2 expression influences axonal growth rate in early sensory neurons in culture. Additional comparative studies of axonal growth rate in bcl-2 mutant and wild-type embryos in vivo will, however, be required in order to assess further the significance of these in vitro observations. Recent evidence suggests that the level of Bcl-2 expression in mouse retinal ganglion cells (RGCs) influences the ability of these cells' axons to regenerate into co-cultured tectal explants [17] . At early fetal stages, RGCs express high levels of Bcl-2 and are able to extend axons into cocultured tectal tissue of the same age, whereas late fetal RGCs express low levels of Bcl-2 and are not able to grow axons into tectal tissue. The regenerative ability of early fetal RGCs is substantially reduced in retinal explants obtained from bcl-2 -/-embryos, and late fetal and adult RGCs from transgenic mice overexpressing Bcl-2 in neurons retain the ability to regenerate into tectal tissue. Likewise, optic nerve axons in Bcl-2-overexpressing transgenic mice show enhanced regenerative capacity following lesion in vivo [17] . Although these observations provide evidence that Bcl-2 can promote axonal regeneration in the central nervous system, their significance for the role of endogenous Bcl-2 in the regulation of the growth of axons to their target during development is uncertain. Furthermore, because the numbers of regenerating RGCs, rather than the growth rates of individual axons, were measured in this study, it is unclear whether the level of Bcl-2 expression affects the growth rate of regenerating axons or simply affects the proportion of neurons that are able to regenerate following axotomy.
Several previous studies of tumour cell lines have also raised the possibility that Bcl-2 might play a role in neuronal differentiation. First, Bcl-2 overexpression in a neural crest-derived cell line enhanced the outgrowth of neurite-like processes and increased the expression of neuron-specific enolase [18] . Second, midbrain-derived dopaminergic cell lines stably expressing bcl-2 extended longer neurites than control transfected cells but did not show increased expression of many neuron-specific proteins [19] . Finally, Bcl-2 enhanced the differentiation of the PC12 neural cell line into sympathetic-like neurons when these cells were grown without serum but not when grown with serum [20] . The physiological and developmental significance of overexpressing bcl-2 in tumour cell lines is, however, difficult to interpret.
In summary, our findings are consistent with a novel function for endogenously expressed bcl-2 in embryonic sensory neurons shortly after they differentiate from progenitor cells and start extending axons to their targets. At this stage of development, bcl-2 appears to enhance the rate of axonal growth. This action of bcl-2 is not related to its well characterised anti-apoptotic role and may provide an explanation for the widespread expression of bcl-2 in embryonic nervous system during the earliest stages of neuronal development [21, 22] , even though enhanced degeneration of neurons in bcl-2-deficient mice is not observed until the postnatal period [11] .
Materials and methods
Mutant mice (bcl-2 +/-) were a generous gift of Dennis Loh [2, 3] . Embryos were obtained from overnight matings of bcl-2 +/-mice. Pregnant females were killed after 11 and 12 days gestation and the genotypes of the embryos were determined by a PCR-based technique using DNA isolated from embryonic tissues. There were no consistent differences in the stage of development of wild-type and bcl-2-deficient embryos in each litter using the staging criteria of Theiler [23] .
Separate dissociated cultures of trigeminal ganglion neurons were established from each embryo. The neurons were cultured in 60 mm diameter poly-ornithine/laminin-coated plastic tissue culture dishes at a Where error bars are not shown, they would be smaller than the symbols representing the different genotypes density of approximately 500 neurons per dish in 5 ml serum-free medium [24] . Serial measurements of axonal length of the same neurons were made at intervals between 6 and 48 h in culture by identifying the position of individual neurons within a grid drawn on the underside of the dishes and making accurate serial drawings of the axons of each neuron with the aid of a drawing tube [25] . The total axon length of these bipolar sensory neurons was determined by tracing the drawings onto a digitising pad linked to a computer. The means and standard errors of the serial measurements taken from cohorts of neurons in all experiments are reported. To exclude any differences in axonal growth rate that could arise as a consequence of differences in neuronal viability, only neurons that survived throughout the 48 h culture period were included in the analysis. The percentage survival in each cohort was also determined by counting the number of neurons surviving in each cohort after 48 h and expressing this as a percentage of the initial number of neurons in the cohort.
